{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:13:38Z","timestamp":1761815618110,"version":"build-2065373602"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SingHealth Polyclinics Collaborative Research Grant","award":["SHPCG-CRGMay22-01"],"award-info":[{"award-number":["SHPCG-CRGMay22-01"]}]},{"name":"National Research Foundation, Prime Minister\u2019s Office","award":["Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program"],"award-info":[{"award-number":["Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program","Campus for Research Excellence and Technological Enterprise (CREATE) program"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11865-8","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:09:04Z","timestamp":1761815344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of COVID-19 neutralizing antibodies among multi-ethnic staff of an Asian primary healthcare institution: insights from point-of-care testing and implications for booster vaccination decisions"],"prefix":"10.1186","volume":"25","author":[{"given":"Prawira","family":"Oka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patthara","family":"Kongsuphol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Say Yong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivekanandan","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirk Jenn","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aminath Shiwaza","family":"Moosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengfei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih Ying","family":"Gun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Ping Marianne","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayshini","family":"Vijaykumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra Xin Yi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrina W. L.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon Y. H.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E.","family":"McBee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Preiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadley D.","family":"Sikes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngiap Chuan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"11865_CR1","doi-asserted-by":"publisher","first-page":"1023507","DOI":"10.3389\/fmed.2022.1023507","volume":"9","author":"ME Flacco","year":"2022","unstructured":"Flacco ME, Acuti Martellucci C, Baccolini V, De Vito C, Renzi E, Villari P, et al. COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front Med (Lausanne). 2022;9:1023507.","journal-title":"Front Med (Lausanne)."},{"issue":"10309","key":"11865_CR2","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","volume":"398","author":"SY Tartof","year":"2021","unstructured":"Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson K, Ranasinghe ON, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398(10309):1407\u201316 https:\/\/ssrn.com\/abstract=3909743.","journal-title":"Lancet."},{"key":"11865_CR3","doi-asserted-by":"crossref","unstructured":"Fleischmann CJ, Bulman CA, Yun C, Lynch KL, Wu AHB, Whitman JD. Detection of IgM, IgG, IgA and neutralizing antibody responses to SARS-CoV-2 infection and mRNA vaccination. J Med Microbiol. 2023;72(1):10.1099\/jmm.0.001632.","DOI":"10.1099\/jmm.0.001632"},{"issue":"6576","key":"11865_CR4","first-page":"43","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, et al. Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. Science (1979). 2022;375(6576):43\u201350.","journal-title":"Science (1979)"},{"issue":"7","key":"11865_CR5","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205\u201311.","journal-title":"Nat Med"},{"key":"11865_CR6","doi-asserted-by":"publisher","first-page":"06001","DOI":"10.7189\/jogh.13.06001","volume":"13","author":"AM Utami","year":"2023","unstructured":"Utami AM, Rendrayani F, Khoiry QA, Noviyanti D, Suwantika AA, Postma MJ, et al. Economic evaluation of COVID-19 vaccination: A systematic review. J Glob Health. 2023;13:06001.","journal-title":"J Glob Health."},{"key":"11865_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijid.2022.03.029","volume":"119","author":"R Li","year":"2022","unstructured":"Li R, Liu H, Fairley CK, Zou Z, Xie L, Li X, et al. Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the united States. Int J Infect Dis. 2022;119:87\u201394.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"11865_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/tropicalmed8020091","volume":"8","author":"K Sirison","year":"2023","unstructured":"Sirison K, Nittayasoot N, Techasuwanna R, Cetthakrikul N, Suphanchaimat R. Cost-Effectiveness analysis of COVID-19 vaccine booster dose in the Thai setting during the period of Omicron variant predominance. Trop Med Infect Dis. 2023;8(2):91.","journal-title":"Trop Med Infect Dis."},{"issue":"4","key":"11865_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.vacun.2023.06.006","volume":"24","author":"A Al-Taie","year":"2023","unstructured":"Al-Taie A, Yilmaz Z. Exploring the intention and hesitancy to receive a booster dose of COVID-19 vaccine among patients with comorbid disease conditions using a health belief model. Vacunas. 2023;24(4):317\u201325.","journal-title":"Vacunas"},{"issue":"5","key":"11865_CR10","doi-asserted-by":"publisher","first-page":"e02257","DOI":"10.1128\/spectrum.02257-22","volume":"10","author":"HL Cheng","year":"2022","unstructured":"Cheng HL, Lim SM, Jia H, Chen MW, Ng SY, Gao X, et al. Rapid evaluation of vaccine booster effectiveness against SARS-CoV-2 variants. Microbiol Spectr. 2022;10(5):e02257-22.","journal-title":"Microbiol Spectr."},{"key":"11865_CR11","doi-asserted-by":"crossref","unstructured":"Kongsuphol P, Jia H, Cheng HL, Gu Y, Shunmuganathan BD\/O, Chen MW et al. A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies. Commun Med. 2021;1:46.","DOI":"10.1038\/s43856-021-00045-9"},{"key":"11865_CR12","doi-asserted-by":"crossref","unstructured":"Lim SM, Cheng HL, Jia H, Kongsuphol P, D\/O Shunmuganathan B, Chen MW et al. Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants. Bioeng Transl Med. 2022;7(2):e10293.","DOI":"10.1002\/btm2.10293"},{"issue":"9","key":"11865_CR13","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1016\/S2468-2667(20)30164-X","volume":"5","author":"LH Nguyen","year":"2020","unstructured":"Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5(9):e475\u201383.","journal-title":"Lancet Public Health"},{"issue":"2","key":"11865_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010892","volume":"19","author":"JT Lim","year":"2023","unstructured":"Lim JT, Tan KB, Abisheganaden J, Dickens BL. Forecasting upper respiratory tract infection burden using high-dimensional time series data and forecast combinations. PLoS Comput Biol. 2023;19(2):e1010892.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"11865_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12874-022-01694-7","volume":"22","author":"L Naing","year":"2022","unstructured":"Naing L, Nordin R, Bin, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using scalex and scalar calculators. BMC Med Res Methodol. 2022;22(1):209.","journal-title":"BMC Med Res Methodol"},{"key":"11865_CR16","unstructured":"Health Sciences Authority Singapore, Full-fledged product registration validation requirements for, covid-19 tests (Professional use only tests). 2020. Available from:\u00a0https:\/\/www.hsa.gov.sg\/medical-devices\/guidance-documents.\u00a0[Cited 2024 Mar 3]."},{"key":"11865_CR17","unstructured":"Emergo. HSA stops accepting new provisional authorization (PA) applications for COVID-19 test kits. 2021 [Cited 2024 Mar 3]. Available from: https:\/\/www.emergobyul.com\/news\/singapore-hsa-explains-new-developments-covid-19-test-kit-authorizations"},{"issue":"9","key":"11865_CR18","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","volume":"38","author":"CW Tan","year":"2020","unstructured":"Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2\u2013spike protein\u2013protein interaction. Nat Biotechnol. 2020;38(9):1073\u20138.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"11865_CR19","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947\u201353.","journal-title":"Nat Hum Behav"},{"issue":"1","key":"11865_CR20","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1186\/s12889-023-17239-6","volume":"23","author":"S Duong","year":"2023","unstructured":"Duong S, Burtniak J, Gretchen A, Mai A, Klassen P, Wei Y, et al. Riding high: Seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020\u2013February 2022. BMC Public Health. 2023;23(1):2420.","journal-title":"BMC Public Health."},{"key":"11865_CR21","doi-asserted-by":"crossref","unstructured":"Jones JM, Opsomer JD, Stone M, Benoit T, Ferg RA, Stramer SL, et al. Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence estimates based on blood donations, July 2020-December 2021. JAMA. 2022;328(3):298\u2013301.","DOI":"10.1001\/jama.2022.9745"},{"issue":"1","key":"11865_CR22","doi-asserted-by":"publisher","first-page":"7817","DOI":"10.1038\/s41598-024-58498-6","volume":"14","author":"S Ezzikouri","year":"2024","unstructured":"Ezzikouri S, Tajudeen R, Majidi H, Redwane S, Aqillouch S, Abdulaziz M, et al. Seroepidemiological assessment of SARS-CoV-2 vaccine responsiveness and associated factors in the vaccinated community of the Casablanca-Settat Region, Morocco. Sci Rep. 2024;14(1):7817.","journal-title":"Sci Rep."},{"key":"11865_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micinf.2022.105077","volume":"25","author":"D Jacot","year":"2023","unstructured":"Jacot D, von Rotz U, Pellaton C, Blondet F, Aebischer O, Perreau M, et al. SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection. Microbes Infect. 2023;25(1-2):105077.","journal-title":"Microbes Infect"},{"issue":"10328","key":"11865_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924\u201344.","journal-title":"Lancet"},{"issue":"4","key":"11865_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/vaccines10040621","volume":"10","author":"M Lounis","year":"2022","unstructured":"Lounis M, Bencherit D, Rais MA, Riad A. COVID-19 vaccine booster hesitancy (VBH) and its drivers in algeria: National Cross-Sectional Survey-Based study. Vaccines (Basel). 2022;10(4):621.","journal-title":"Vaccines (Basel)."},{"key":"11865_CR26","doi-asserted-by":"crossref","unstructured":"Alalawi M, Alsalloum MA, Garwan YM, Abuzeid M, Alalawi H, Eljaaly K, et al. COVID-19 vaccine hesitancy among healthcare workers in Arab countries: a systematic review and meta-analysis. PLoS ONE. 2024;19(1).","DOI":"10.1371\/journal.pone.0296432"},{"issue":"6","key":"11865_CR27","first-page":"948","volume":"10","author":"CJ Peterson","year":"2022","unstructured":"Peterson CJ, Lee B, Nugent K. COVID-19 vaccination hesitancy among healthcare Workers\u2014A. Rev Vaccines (Basel). 2022;10(6):948.","journal-title":"Rev Vaccines (Basel)."},{"issue":"8","key":"11865_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/17476348.2021.1917389","volume":"15","author":"DS Mouliou","year":"2021","unstructured":"Mouliou DS, Gourgoulianis KI. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev Respir Med. 2021;15(8):993\u20131002.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"11865_CR29","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1186\/s12913-021-07200-x","volume":"21","author":"A Faramarzi","year":"2021","unstructured":"Faramarzi A, Javan-Noughabi J, Tabatabaee SS, Najafpoor AA, Rezapour A. The lost productivity cost of absenteeism due to COVID-19 in health care workers in iran: a case study in the hospitals of Mashhad university of medical sciences. BMC Health Serv Res. 2021;21(1):1169.","journal-title":"BMC Health Serv Res."},{"issue":"1","key":"11865_CR30","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1038\/s41467-023-38477-7","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Zeng W, Kabubei KM, Rasanathan JJK, Kazungu J, Ginindza S, et al. Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries. Nat Commun. 2023;14(1):2791.","journal-title":"Nat Commun."},{"key":"11865_CR31","unstructured":"Lim V, Channel News A. 2023. No increase in demand for COVID-19 vaccines from visitors, private patients: MOH. [Cited 2024 Mar 3] Available from: https:\/\/www.channelnewsasia.com\/singapore\/covid-19-vaccines-demand-visitors-tourists-private-patients-singapore-moh-china-reopening-3211326"},{"key":"11865_CR32","unstructured":"World Health Organization, Delivered by women, led by men: a gender and equity analysis of the global health and social workforce. Human Resources for Health Observer Series No. 24. Geneva: WHO; 2019. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/healthworkforce\/delivered-by-women-led-by-men.pdf?sfvrsn=94be9959_2"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11865-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11865-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:09:22Z","timestamp":1761815362000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11865-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11865"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11865-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by SingHealth Centralised Institution Review Board (CIRB Ref: 2022\/2101). The lead author attended the Good Clinical Practice Workshop and conducted the study in accordance with the Declaration of Helsinki. All subjects provided written consent before their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors HJ, PK, MEM, PRP, and HDS declare that they are co-founders of Thrixen Pte Ltd (Singapore). All other authors declare no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1450"}}